Relative Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations In Healthy Volunteers Under Fasting Conditions.

Trial Profile

Relative Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations In Healthy Volunteers Under Fasting Conditions.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Cardiovascular disorders; Erectile dysfunction
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Jun 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
    • 26 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top